Bristol-Myers Squibb saw the highest growth of 1.07% in patent filings and 1.09% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.9% and grants by 1.02%. GlobalData’s DataBook provides a comprehensive analysis of Bristol-Myers Squibb‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Bristol-Myers Squibb has been focused on protecting inventions in United States(US) with 90 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 26% filings and 15% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where Bristol-Myers Squibb is filings its patents. Among the top granted patent authorities, Bristol-Myers Squibb has 18% of its grants in Spain(ES), 17% in China(CN) and 15% in United States(US).
Roche and Johnson & Johnson could be the strongest competitors for Bristol-Myers Squibb
In terms of grant share, Bristol-Myers Squibb stands first among its competitors followed by Roche and Johnson & Johnson.
Patents related to rare diseases and cell & gene therapy lead Bristol-Myers Squibb's portfolio
Bristol-Myers Squibb has the highest number of patents in rare diseases followed by, cell & gene therapy and genomics. For rare diseases, nearly 46% of patents were filed and 46% of patents were granted in Q2 2024.
Lymphoma related patents lead Bristol-Myers Squibb portfolio followed by leukemia, and cell therapy
Bristol-Myers Squibb has highest number of patents in lymphoma followed by leukemia, cell therapy, multiple myeloma (kahler disease), and ovarian cancer. For lymphoma, nearly 3% of patents were filed and 2% of patents were granted in Q2 2024.
For comprehensive analysis of Bristol-Myers Squibb's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
